The Limited Times

Now you can see non-English news...

Covid-19: vaccination extended to cystic fibrosis patients under 50

2021-04-08T10:13:53.785Z


Cystic fibrosis patients under the age of 50, so far not eligible for vaccination against Covid-19, can now receive the Pfizer and Moderna vaccines, a patient association announced Thursday, April 8, letter from Olivier Véran supporting. Read also: Vaccines: first injections at the Stade de France " Patients with cystic fibrosis aged under 50 can now be vaccinated, " wrote the Minister of Health


Cystic fibrosis patients under the age of 50, so far not eligible for vaccination against Covid-19, can now receive the Pfizer and Moderna vaccines, a patient association announced Thursday, April 8, letter from Olivier Véran supporting.

Read also: Vaccines: first injections at the Stade de France

"

Patients with cystic fibrosis aged under 50 can now be vaccinated,

" wrote the Minister of Health in a letter dated March 31, addressed to the association Vaincre la Mucoviscidose.

"

It is a relief

", reacted in a press release this organization, which had asked in February to the government "

to ensure effective and immediate access

" to vaccination for the patients it represents.

Until now, cystic fibrosis was one of the “

comorbidities

” qualifying for vaccination for people aged 50 to 69 years.

From now on, this pathology will make it possible to receive the Moderna vaccine from the age of 18, or the Pfizer from the age of 16.

For younger children, "

certain exceptional situations could lead to prescriptions without marketing authorization

", for example in the case of lung transplants, adds the association.

Source: lefigaro

All news articles on 2021-04-08

You may like

Life/Entertain 2024-03-16T06:06:14.437Z

Trends 24h

Latest

© Communities 2019 - Privacy

The information on this site is from external sources that are not under our control.
The inclusion of any links does not necessarily imply a recommendation or endorse the views expressed within them.